Integra LifeSciences (IART) vs Tandem Diabetes Care (TNDM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Tandem Diabetes Care (TNDM) has outperformed Integra LifeSciences (IART) over the past year, gaining 2.2% versus a loss of 9.5%. Over five years, IART leads with a -80.2% price change compared with -87.5% for TNDM. Tandem Diabetes Care is the larger company by market cap ($1.09 billion vs $1.05 billion), about 1.0 times the size.
On valuation, Integra LifeSciences trades at a lower forward P/E (5.2x vs 98.5x for Tandem Diabetes Care).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IART | TNDM |
|---|---|---|
| Share price | $13.50 | $15.67 |
| Market cap | $1.05B | $1.09B |
| 1-day change | +0.67% | -0.06% |
| YTD return | +7.97% | -28.69% |
| 1-year return | -9.45% | +2.18% |
| 5-year return | -80.19% | -87.50% |
| Forward P/E | 5.20 | 98.55 |
| EPS (TTM) | $-0.09 | $-0.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $20.49 | $29.65 |
| 52-week low | $8.70 | $12.26 |
| Distance from 52-week high | -34.11% | -47.17% |
| Analyst consensus | hold | buy |
| Avg. price target upside | +36.15% | +77.85% |
| Average volume | 916.55K | 2.01M |
| Shares outstanding | 77.77M | 69.58M |
| Employees | 4,427 | 2,500 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TNDM has outperformed IART by 11.6 percentage points over the past year.
About Integra LifeSciences
IART stock →Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments.
Health Care · Medical/Dental Instruments · 4,427 employees
About Tandem Diabetes Care
TNDM stock →Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
Health Care · Medical/Dental Instruments · 2,500 employees
IART vs TNDM FAQ
Which is bigger, Integra LifeSciences or Tandem Diabetes Care?
Tandem Diabetes Care (TNDM) is larger, with a market capitalization of $1.09B compared with $1.05B for Integra LifeSciences (IART).
Which stock has performed better over the past year, IART or TNDM?
TNDM returned +2.18% over the past 12 months, compared with -9.45% for IART (price return, excluding dividends). Past performance does not predict future results.
Are Integra LifeSciences and Tandem Diabetes Care in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.